GRI Bio Announces Closing of $8.0 Million Public Offering
LA JOLLA, CA, Dec. 12, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a...
Year: 2025
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Dec. 12, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company...
NervGen Pharma Announces Proposed Amendment to Warrants
Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF) ("NervGen" or the "Company"),...
MyndTec Inc. Completes Ninth Tranche of Non-Brokered Private Placement
Mississauga, Ontario--(Newsfile Corp. - December 12, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), a neurological treatment and rehabilitation...
Dominari Holdings Announces Change of Record Date and Payment Date for $10 Million Cash Dividend
NEW YORK, Dec. 12, 2025 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) is pleased to announce that, following its press release...
ISHI Health Launches Virtual Heart Failure Clinics in California and Arizona
SAN DIEGO, Dec. 12, 2025 /PRNewswire/ -- ISHI Health, an innovator in AI-enabled virtual cardiac care, today announced the launch...
Zealthy Review 2026: How Zealthy Compares to FitRx and RoenRx for Weight Loss & GLP-1 Care
LOS ANGELES, CA / ACCESS Newswire / December 12, 2025 / The landscape of weight management has undergone a seismic...
Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements
ESTERO, FL / ACCESS Newswire / December 12, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a...
VSee Health, Inc. Announces Postponement of Annual Meeting of Stockholders Until December 30, 2025
SAN JOSE, CALIFORNIA / ACCESS Newswire / December 12, 2025 / VSee Health, Inc. (NASDAQ:VSEE) a leader in innovative telemedicine...
Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance
Issued on behalf of Oncolytics Biotech Inc.VANCOUVER, BC, Dec. 12, 2025 /PRNewswire/ -- USANewsGroup.com News Commentary – Scientists developed an antibody treatment that...
BoomRx Debuts Single Portal for Prescription Sourcing and Fulfillment
New Technology Platform Reduces Administrative Burden for Healthcare Providers NationwideTAMPA, Fla., Dec. 12, 2025 /PRNewswire/ -- BoomRx, a fast-growing national...
CluePoints Scoops Prestigious 2025 Scrip Award
RBQM and AI leader wins the 'Best Contract Research Organization – Specialist Providers' categoryKING OF PRUSSIA, Pa., Dec. 12, 2025...
Global Attention: POGMENT Biomimetic Collagen “Stable Triple-Helix Breakthrough” –Unconventional and Astonishing
— LivingPhoenix Forum's 12 Conference Presentation Ignite International and Domestic Academia, Hailed by Academicians as the "iPhone Moment for Extracellular...
Acclinate Named Bronze Winner for Digital Health Innovation at the 5th Annual Anthem Awards
BIRMINGHAM, Ala., Dec. 12, 2025 /PRNewswire/ -- Acclinate announced today that its community platform, NOWINCLUDED, has been selected as a...
Cadrenal’s Quiet Expansion Play Is Starting to Get Loud
PONTE VEDRA, FL / ACCESS Newswire / December 12, 2025 / Cadrenal Therapeutics (NASDAQ:CVKD) entered the back half of the...
Cadrenal’s Anticoagulation Platform Is Expanding in a $40 Billion Market
PONTE VEDRA, FL / ACCESS Newswire / December 12, 2025 / Cadrenal Therapeutics (NASDAQ:CVKD) believes it continues to be misread...
NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and ‘FEED’
New ticker symbol, “FEED” will begin trading on the Nasdaq at the open of the market on December 12, 2025...
Smart Meter and eClinicalWorks More Than Double RPM Adoption in 2025, Powering a New Era of Connected Care for Patients
TAMPA, Fla.--(BUSINESS WIRE)--Smart Meter, the leader in Cellular RPM™ and the nation’s most trusted source of patient-generated vital health data,...
BrainCheck Awarded $500K NIH SBIR Phase I Grant to Advance eConsult Platform for Cognitive Care
AUSTIN, Texas--(BUSINESS WIRE)--#CognitiveHealth--BrainCheck, the leading FDA Class II digital cognitive assessment and care platform, has been awarded a $500,000 SBIR...
VSee Health, Inc. Regains Compliance with Nasdaq Stockholders’ Equity Requirement
SAN JOSE, CALIFORNIA / ACCESS Newswire / December 12, 2025 / VSee Health, Inc. (Nasdaq:VSEE, VSEEW), a leading provider of...